"Designing Growth Strategies is in our DNA"

Diabetic Nephropathy Market Size, Share & Industry Analysis, By Drug Class (Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers, Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors, Mineralocorticoid Receptor Antagonists, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Others), and Regional Forecast, 2024-2032

Last Updated: February 24, 2025 | Format: PDF | Report ID: FBI102012

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Key Industry Developments – Merges, Acquisitions, and Partnerships
    2. New Product Launches, By Key Players
    3. Prevalence of Diabetic Nephropathy, By Key Countries
    4. Pipeline Analysis (Analysis by Stage, Route of Administration, Molecule Type, Sponsor, etc.)
    5. Insights on Usage of SGLT2 Inhibitors in CKD Stage 3 Patients
    6. Drugs Delaying Dialysis Onset: Analysis of Ongoing Studies
    7. List of Research & Educational Institutes in R&D
    8. Impact of COVID 19 on the Global Diabetic Nephropathy Market
  5. Global Diabetic Nephropathy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Angiotensin Converting Enzyme (ACE) Inhibitors
      2. Angiotensin Receptor Blockers
      3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
      4. Mineralocorticoid Receptor Antagonists
      5. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Diabetic Nephropathy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Angiotensin Converting Enzyme (ACE) Inhibitors
      2. Angiotensin Receptor Blockers
      3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
      4. Mineralocorticoid Receptor Antagonists
      5. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Others
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Diabetic Nephropathy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Angiotensin Converting Enzyme (ACE) Inhibitors
      2. Angiotensin Receptor Blockers
      3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
      4. Mineralocorticoid Receptor Antagonists
      5. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
  8. 7.3.4.I taly
      1. Spain
      2. Scandinavia
      3. Rest of Europe
  9. Asia Pacific Diabetic Nephropathy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Angiotensin Converting Enzyme (ACE) Inhibitors
      2. Angiotensin Receptor Blockers
      3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
      4. Mineralocorticoid Receptor Antagonists
      5. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  10. Rest of the World Diabetic Nephropathy Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Angiotensin Converting Enzyme (ACE) Inhibitors
      2. Angiotensin Receptor Blockers
      3. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
      4. Mineralocorticoid Receptor Antagonists
      5. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Others
  11. Comparative Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Janssen Pharmaceuticals, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. AstraZeneca
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Aurobindo Pharmaceuticals
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Novartis AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Sanofi
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Bayer AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Par Pharmaceutical
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Sun Pharmaceutical Industries
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 01: Global Diabetic Nephropathy Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 02: Global Diabetic Nephropathy Market Revenue Share (%), By Drug Class, 2023 & 2032

Figure 03: Global Diabetic Nephropathy Market Revenue Share (%), By Distribution Channel, 2023 & 2032

Figure 04: Global Diabetic Nephropathy Market Value (USD billion), by Region, 2023 & 2032

Figure 05: North America Diabetic Nephropathy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 06: North America Diabetic Nephropathy Market Value Share (%), by Drug Class, 2023

Figure 07: North America Diabetic Nephropathy Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 08: North America Diabetic Nephropathy Market Value Share (%), by Distribution Channel, 2023

Figure 09: North America Diabetic Nephropathy Market Value (USD billion), by Country, 2023 & 2032

 Figure 10: North America Diabetic Nephropathy Market Value Share (%), by Country, 2023

Figure 11: Europe Diabetic Nephropathy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 12: Europe Diabetic Nephropathy Market Value Share (%), by Drug Class, 2023

Figure 13: Europe Diabetic Nephropathy Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 14: Europe Diabetic Nephropathy Market Value Share (%), by Distribution Channel, 2023

Figure 15: Europe Diabetic Nephropathy Market Value (USD billion), by Country/Sub-Region, 2023 & 2032

Figure 16: Europe Diabetic Nephropathy Market Value Share (%), by Country/Sub-Region, 2023

Figure 17: Asia Pacific Diabetic Nephropathy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 18: Asia Pacific Diabetic Nephropathy Market Value Share (%), by Drug Class, 2023

Figure 19: Asia Pacific Diabetic Nephropathy Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 20: Asia Pacific Diabetic Nephropathy Market Value Share (%), by Distribution Channel, 2023

Figure 21: Asia Pacific Diabetic Nephropathy Market Value (USD billion), by Country/Sub-Region, 2023 & 2032

Figure 22: Asia Pacific Diabetic Nephropathy Market Value Share (%), by Country/Sub-Region, 2023

Figure 23: Rest of the World Diabetic Nephropathy Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 24: Rest of the World Diabetic Nephropathy Market Value Share (%), by Drug Class, 2023

Figure 25: Rest of the World Diabetic Nephropathy Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 26: Rest of the World Diabetic Nephropathy Market Value Share (%), by Distribution Channel, 2023

Figure 27: Global Diabetic Nephropathy Market Share (%), By Company, 2023

Table 01: Global Diabetic Nephropathy Market Revenue (USD billion) Forecast, By Drug Class, 2019-2032

Table 02: Global Diabetic Nephropathy Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 03: Global Diabetic Nephropathy Market Revenue (USD billion) Forecast, By Region, 2019-2032

Table 04: North America Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 05: North America Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 06: North America Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Country, 2019–2032

Table 07: Europe Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 08: Europe Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 09: Europe Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032

Table 10: Asia Pacific Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 11: Asia Pacific Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 12: Asia Pacific Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032

Table 13: Rest of the World Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 14: Rest of the World Diabetic Nephropathy Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Diabetic Nephropathy Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 120
Consulting Services
    How will you benefit from our consulting services ?